Brooklyn Therapeutics CEO Howard Federoff joins the Watch List to discuss future growth prospects for the company amid the rapidly evolving biopharmaceutical environment. Brooklyn Therapeutics is focused on Cytokine-based therapies in treating patients with cancer, and is also engaged in developing IRX-2.
24 Jun 2021
The Watch List
28 Apr 2022
The Watch List
20 Apr 2022
The Watch List
13 May 2022
Trading 360
18 Apr 2022
Market On Close
20 May 2022
Market On Close
20 May 2022